Detrimental effects of mechanical stretch on smooth muscle function in saphenous veins  by Hocking, Kyle M. et al.
From the Southern Association for Vascular Surgery
Detrimental effects of mechanical stretch on
smooth muscle function in saphenous veins
Kyle M. Hocking, BE,a Colleen Brophy, MD,a,b Syed Z. Rizvi, MD,a Padmini Komalavilas, PhD,a,b
Susan Eagle, MD,c Marzia Leacche, MD,d Jorge M. Balaguer, MD,b,d and
Joyce Cheung-Flynn, PhD,a Nashville, Tenn
Objective: This study evaluated the smooth muscle functional response and viability of human saphenous vein (HSV)
grafts after harvest and explored the effect of mechanical stretch on contractile responses of porcine saphenous vein
(PSV).
Methods: The contractile responses (stress, 105 N/m2) of deidentified, remnant HSV grafts to depolarizing potassium
chloride and the agonist norepinephrine were measured in a muscle organ bath. Cellular viability was evaluated using a
methyl thiazole tetrazolium (MTT) assay. A PSVmodel was used to evaluate the effect of radial, longitudinal, and angular
stretch on smooth muscle contractile responses.
Results: Contractile responses varied greatly in HSV harvested for autologous vascular and coronary bypass procedures
(0.04198  0.008128  105 N/m2 to 0.1192  0.02776  105 N/m2). Contractility of the HSV correlated with the
cellular viability of the grafts. In the PSVmodel, manual radial distension of>300 mmHg had no impact on the smooth
muscle responses of PSV to potassium chloride. Longitudinal and angular stretch significantly decreased the contractile
function of PSV by 33.16% and 15.26%, respectively (P < .03).
Conclusions: There is considerable variability in HSV harvested for use as an autologous conduit. Longitudinal and
angular stretching during surgical harvest impairs contractile responsiveness of the smooth muscle in saphenous vein.
Avoiding stretch-induced injuries to the conduits during harvest and preparation for implantation may reduce adverse
biologic responses in the graft (eg, intimal hyperplasia) and improve patency of autologous vein graft bypasses. ( J Vasc
Surg 2011;53:454-60.)
Clinical Relevance: Human great saphenous vein remains the most commonly used conduit for coronary artery bypass
grafting and peripheral vascular revascularization. The techniques commonly used for surgical saphenous vein harvest can
produce significant injury to the conduit and elicit an exuberant physiologic healing response in the vessel walls, leading
to the development of intimal hyperplasia. Intimal hyperplasia is thought to involve smooth muscle proliferation,
migration, phenotypic modulation, and extracellular matrix deposition, and ultimately, lead to graft occlusion. This
study shows that mechanical stretching injures vascular smooth muscle and reduces contractile responsiveness of the
saphenous vein. Thus, by understanding how these injuries can be minimized, mortality and costs associated with vein



















aHuman saphenous vein (HSV) continues to be the
most commonly used conduit for autologous coronary
artery bypass grafting (CABG) and peripheral vascular
(PV) surgery.1 Failure of the vein grafts remains a major
limitation of these procedures. The vein graft failure rate
per patient in 1920 patients at 12 to 18 months in the
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454roject of Ex-vivo Vein Graft Engineering via Transfec-
ion (PREVENT) IV trial was 45%.2
Intimal hyperplasia, a response to injury, remains the
eading cause of vein graft failure. Although the precise
echanism is not completely understood, intimal hyperpla-
ia results from a cascade of molecular and cellular events
hat are triggered by injury. Intimal hyperplasia is a complex
rocess involving vascular smooth muscle proliferation,
igration, phenotypic modulation of the smooth muscle
ells from a contractile to a synthetic phenotype, and extra-
ellular matrix production.3,4 Intimal hyperplasia will de-
elop to varying degrees in the vein graft after its insertion
nto the arterial circulation.5 In general, intimal hyperplasia
s a self-limiting process; however, in focal areas, it can lead
o significant lumen compromise.6-8 The focal areas of
tenoses are usually located at sites of conduit abnormalities
r of unrepaired defects.8 This process leads to pathologic
arrowing of the vessel lumen, graft stenoses, and ulti-
ately, graft failure.9
The morphologic integrity of the vein graft conduit
nd its integrity before implantation as a graft are important
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Volume 53, Number 2 Hocking et al 455harvesting and handling of the conduit play a significant
role in the patency of vein grafts.10 Although the effect of
endothelial injury has been the subject of numerous inves-
tigations, few studies have evaluated smooth muscle func-
tional viability of the vein graft. Vascular smooth muscle is
the contractile component of veins and arteries, and the
control of relaxation and contraction depends on exposure
to both intrinsic (eg, nitric oxide, metabolic changes) and
extrinsic (eg, environmental stressors) stimuli. Integration
of these signals is reflected in the modulation of intracellu-
lar calcium and cyclic guanosine monophosphate that are
fundamentally important in determining vascular reactivity,
smooth muscle proliferation, and phenotype of the tissues.
Physiologic adaptation is one of the critical attributes of
early vein graft remodeling. The vein tunica media consists
predominantly of smooth muscle cells that are oriented both
longitudinally and circumferentially, whereas arterial orienta-
tion is longitudinal and spiral, a manner better suited to
conduct the arterial pulse. Saphenous vein has an active myo-
genic response in which it contracts to acute increases in
luminal pressure, a unique property that allows it to respond
to rapid changes in pressure when a person moves from a
recumbent to standing position.11 With exposure to arterial
flow, this reflex is enhanced if not sustained with an increased
sensitivity to phenylephrine and catecholamine, leading to
increased tension in smooth muscle.12,13 Taken together,
smooth muscle viability and function is important for optimal
adaptation into the arterial circulation.
The present study evaluated the contractile responsive-
ness of smooth muscle in vein grafts harvested for coronary
and peripheral reconstructions. We also used a porcine saphe-
nous vein (PSV) model to study the effect of intraoperative
manipulation on smooth muscle function. We hypothesized
that stretch-induced injuries incurred during vein harvest re-
duce smooth muscle functional viability of the conduits.
METHODS
Material and reagents. All chemicals were purchased
from Sigma (St. Louis, Mo) unless specified otherwise.
Procurement of HSV. Sixty deidentified remnants of
HSVwere collected from patients undergoingCABG and PV
surgery after approval of the Institutional Review Boards of
the Vanderbilt University Medical Center and the VA Ten-
nessee Valley Healthcare System, Nashville, TN. The HSVs
were harvested by open or minimally invasive endoscopic
technique according to the discretion of the surgeons. The
HSVs were stored in heparinized saline solution until the end
of the surgical procedure, at which time they were placed in
cold University of Wisconsin (UW) transplant harvest buffer
(100 mM potassium lactobionate, 25 mM KH2PO4, 5 mM
MgSO4, 30 mM raffinose, 5 mM adenosine, 3 mM glutathi-
one, 1 mM allopurinol, 50 g/L hydroxyethyl starch [Cell
Preservation Solutions, Adelphia, NJ], pH 7.4) at 4°C. The
HSVswere tested24 hours of harvest.UWorgan transplant
solution has been shown to preserve viability ofHSV for up to
48 hours without significant loss to vasoreactivity.14 Upon
gross inspection of the segments, regions of the grafts that
were damaged by forceps or clamps were discarded. Only segions that were without damage or branches were used for
nalysis.
Animal study. All animal procedures followed institu-
ional guidelines for the care and use of laboratory animals.
he study protocol was approved by Vanderbilt Institu-
ional Animal Care and Use Committee. PSVs from eutha-
ized pigs were dissected using an open harvest “no-touch”
echnique and placed in UW transplant harvest buffer at
°C and tested 24 hours of harvest.
Physiologic measurements of smooth muscle
unction. Rings (1 mm wide) were cut from segments of
SV and dissected free of fat and connective tissue. The
ings were weighed and their lengths recorded. To focus on
mooth muscle responses, the endothelium was mechani-
ally denuded by gently rolling the luminal surface of each
ing at the tip of a fine vascular forceps15 before suspension
n a muscle bath containing a bicarbonate buffer (120 mM
aCl, 4.7 mM KCl, 1.0 mMMgSO4, 1.0 mM NaH2PO4,
0 mM glucose, 1.5 mM CaCl2, and 25 mM Na2HCO3,
H 7.4), equilibrated with 95% oxygen and 5% carbon
ioxide at 37°C.
Each ring was progressively stretched to its optimal
esting tension (approximately 1 g) that would produce a
aximal response to contractile agonists, as determined
reviously.16,17 The rings were stretched to 4 g of tension
nd then maintained at the resting tension and equilibrated
or a minimum of 2 hours. Force measurements were
btained using a Radnoti Glass Technology (Monrovia,
alif) force transducer (159901A) interfaced with a
owerLab data acquisition system and Chart software (A D
nstruments, Colorado Springs, Colo).
We first characterized smooth muscle functional viabil-
ty in response to a potassium challenge, which causes
epolarization of the membrane and leads to contraction of
unctionally viable smooth muscle.18 HSV rings were con-
racted repeatedly with 110 mM KCl (with equimolar
eplacement of NaCl in bicarbonate buffer) until the max-
mal response was generated. Tissues that failed to respond
o KCl were not tested further. Rings that generated a
tress meeting our defined criteria for viability were
ashed to remove the KCl and equilibrated in the bicar-
onate solution for 30 minutes. Contractile response of
aphenous vein rings to a physiologic agonist, norepi-
ephrine (107 to 106 M), was then tested.
Cellular viability assay. To quantitate cellular viabil-
ty, a modified methyl thiazole tetrazolium (MTT) assay
as used.19 In this colormetric assay, MTT is reduced by a
itochondrial enzyme in living cells to formazan, an insol-
ble purple product. The resulting product is then ex-
racted from the tissues with a solvent and measured spec-
rophotometrically. Briefly, four separate rings were cut
rom each HSV (n  13). These fresh rings were not
ubjected to muscle bath equilibration or vasocontractility
esting. One ring was placed in water and microwaved for
0 minutes to serve as a control. Each ring was placed in
50 L of 0.1% (1 mg/mL) MTT in phosphate-buffered
aline and incubated at 37°C for 1 hour. The reaction was
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placed in 1 mL of CelloSolve solution for 4 hours at 37°C
to extract the resulting pigment from the tissues. The
concentration of the pigments was measured spectropho-
tometrically at 570 nm. The viability index was expressed as
OD570/mg/mL.
Mechanical stretch of PSV. We evaluated the intra-
operative mechanical handling maneuvers that may cause
injury to saphenous veins. PSVs were subjected to one of
the following: distension, longitudinal stretch, or angular
stretch. To distend the veins, PSVs (n 4) were cannulated
proximally and distally with a bullet tip needle (Medtronic,
Minneapolis, Minn), secured with a 4-0 silk suture. Pres-
sure was measured at the distal end with a manometer with
a maximum measurement capacity of 300 mm Hg. Hepa-
rinized saline in a syringe was then injected at a pressure
300 mm Hg for 2 minutes.
To perform longitudinal stretch injury, PSVs (n  4)
were secured at each end with a clamp, stretched to 200% of
original length, and held in the position for 15 seconds.
This was repeated three times. Angular stretch was per-
formed by securing each end of the PSV (n 4) between
two fixed points, and the PSV was lifted upward with a
right angle clamp until maximum resistance was met.
This position was maintained for 15 seconds. This was re-
peated three times. Rings of 1-mm width were cut and the
endothelium denuded. Functional viability of the tissues was
tested as described for HSV.
Data analysis. Contractile response was defined by
stress, which was calculated using the force generated by
the tissues. Stress [105 N/m2] force (g) 0.0987/area,
where area is equal to the wet weight [mg/length (mm at
maximal length)]/1.055],20 and force is the maximum
tension generated in response to high KCl challenge. Any
tissue that generated stress of 0.025  105 N/m2 was
considered functionally viable, which correlates to 0.5 g of
force for a 10-mg, 1-mm-thick, 4-mm-diameter ring. Data
were reported as mean responses  standard error of the
mean. Unpaired t tests were conducted to determine the
significance (P value) of each experiment. A value of P 
.05 was considered statistically significant.
RESULTS
Variable smooth muscle contractile response of
HSV. We collected 60 deidentified HSVs and removed the
endothelium to focus on smooth muscle-derived function.
Denudation of the endothelium was confirmed by exposure
to acetylcholine (5  107 M) of the norepinephrine-
precontracted segment from randomly selected HSVs.15
No relaxation was observed in any HSV, suggesting that
the endothelium was reliably denuded (data not shown).
We first characterized smooth muscle contractile func-
tion in response to a depolarizing potassium challenge.
Smooth muscle functional viability varied greatly in the
HSVs used for vascular reconstruction (Fig 1). Approxi-
mately 33% of the HSV segments were functionally nonvi-
able, with 11 veins failing to generate any contractile re-
sponse to the potassium challenge. A significant difference cn smooth muscle function was also observed (Fig 2) when
he HSV graft segments harvested for CABG were com-
ared with those harvested for PV. CABG veins generated
ignificantly (P  .0015) lower stress to KCl (0.06412 
.01037  105 N/m2, n  26) than PV veins (0.1433 
.02550  105 N/m2, n  12). There was a 55.25%
eduction in smooth muscle functional viability in the
ABG veins (Fig 2,A) compared with the peripheral veins.
HSV that generated stress of 0.025  105 N/m2 in
esponse to 110 mM KCl were considered functionally
iable. This parameter was chosen because HSV producing
ower stress could not be used effectively to measure ago-
ists or the antagonists-induced contractile functions. Via-
le rings were further tested for their response to the
gonist norepinephrine (Fig 2, B). CABG veins generated
ignificantly (P  .003) lower stress to norepinephrine
0.04950  0.009791  105 N/m,2 n  23) than PV
eins (0.1271  0.02959  105 N/m2, n  10). There
as a 61.05% reduction in contractile response to norepi-
ephrine in CABG veins compared with that generated in
V veins (Fig 2, B), a similar extent seen with the KCl
epolarization response.
Functional response correlated with cellular viabil-
ty in HSV. We used an MTT assay to determine if the
ack of contractile response in HSV correlated with viability
f saphenous vein smooth muscle at the cellular level.
mooth muscle function directly correlated with cellular
iability in HSV (Fig 3), implicating that the smooth mus-
ig 1. Smooth muscle contractile responsiveness varied greatly in
emnant saphenous vein grafts. Remnant saphenous veins (n 60)
rom patients undergoing coronary artery bypass or peripheral
ascular revascularization surgery were collected. Rings from each
ein were suspended in a muscle bath, contracted with KCl (110
M), and force wasmeasured and converted to stress (105N/m2).
ach data point represents a vein graft from a different patient, and
hree segments were tested from each patient and averaged. Veins
hat generated stress 0.025  105 N/m2 were considered non-
iable (black) and those that generated stress0.025 105 N/m2
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Volume 53, Number 2 Hocking et al 457a contractile response. Whenever possible, viability of mul-
tiple regions of the grafts was assessed, and no significant
difference was observed along the length of the graft seg-
ment in the MTT index (data not shown). The loss of
cellular viability and contractility may potentially result
from injury during harvest and graft preparation before
implantation.
Mechanical stretch reduced PSV smooth muscle
function viability. We use a PSV model to evaluate the
intraoperative mechanical handling maneuvers that may
cause injury to HSV at the time of harvest and before
implantation. We used PSV, which is of similar caliber as
Fig 2. Contractile response differed in remnant human
patients undergoing perivascular vein (PV) reconstructio
suspended in a muscle bath, contracted with (A) 110 mM
measured and converted to stress (105 N/m2). At least
Data represent averaged stress generated by theHSV colle
of the mean. *P  .05.
Fig 3. Functional response (contractile response to KCl) corre-
lated with cell viability in human saphenous vein grafts. Remnant
human saphenous veins (n 13) were suspended in a muscle bath,
contracted with KCl (110mM), force wasmeasured, and stress was
calculated. Cell viability was determined in other sections of the
same veins using methyl thiazole tetrazolium. The purple precipi-
tate was measured spectrophotometrically (R2  0.7262). Inset,
Representative human saphenous vein rings of (left) low and
(right) high viability index.HSV and represents a model system with less variability in aunction. Distension of PSV to a pressure 300 mm Hg
id not reduce smooth muscle functional viability (data not
hown). When PSVs were subjected to longitudinal stretch
Fig 4, A), a significantly (P  .01) lower stress (0.256 
.021  105 N/m2, n  4) was generated compared with
he nonstretched controls (0.383  0.023 105 N/m2,
 4). Longitudinal stretching of vein segments reduced
mooth muscle functional viability by 33.16%. Angular
tretch reduced smooth muscle contractile function in PSV
y 15.26% (Fig 4, B). PSVs subjected to angular stretch
enerated a significantly (P  .03 ) lower stress (0.422 
.021  105 N/m2, n  4) than nonstretched controls
0.498  0.024  105 N/m2, n  4).
ISCUSSION
In the present study, we assessed physiologic response
f remnant human saphenous vein used for autologous
ascular reconstructions and showed that the smooth mus-
le functional viability of the vein grafts varied greatly, with
3% of the HSV examined in this study nonresponsive to
ontractile challenges after harvest. We showed that viabil-
ty at the cellular level, as determined by an MTT assay,
irectly correlated with the physiologic contractile function
easured in the muscle bath. Our observation implicates
hat the viability and, hence, the functional properties of
hese conduits were compromised at the time of harvest or
uring graft preparation for implantation.
Vein graft patency of CABG surgery is limited by the
evelopment of occlusive intimal hyperplasia. A number of
rugs that have been tested in clinical trials to prevent
ntimal hyperplasia have failed. Antithrombotic and anti-
latelet agents, such as warfarin, clopidogrel, and aspirin,
ave little or no effect on intimal hyperplasia.21 Drug-
luting stents have been shown to be effective in preventing
estenosis after coronary angioplasty; however, there is no
herapeutic agent currently approved for autologous con-
uits.
Two large clinical trials for the prevention of coronary
nous vein grafts. Vein segments (n 38) obtained from
oronary artery bypass grafting (CABG) procedures were
l or (B) 107 to 106 M norepinephrine, and force was
segments were tested from each patient and averaged.
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transcription factors, sequestering these proteins) to pre-
vent smoothmuscle proliferation failed in their primary end
point.2,22 Results from a canine model showed that vein
grafts prepared by an optimal technique that involves min-
imal mechanical manipulation minimize endothelial and
medial injury.9 Despite this, current surgical practices con-
tinue to cause injury in vein grafts. Because intimal hyper-
plasia is a “response to injury” and surgical harvesting of the
vein results in mechanical injury, it follows that ameliorat-
ing injury to the vein graft before implantation will enhance
vein graft patency.
We sought to identify which mechanical manipulations
associated with surgical harvest impair vein graft function.
The forces imposed on a vein during harvest including
shear stress and radial and longitudinal deformation, all of
which may stretch the medial layer and damage contractile
elements. Manual, uncontrolled distension of harvested
veins is a common practice in coronary and PV bypass
surgery in the operating room to reverse vasospasm and to
ligate side branches before final implantation. The disten-
sion pressure exceeds 300 mm Hg, as measured in our
laboratory (data not shown). Okon et al23 reported that
although moderate distension (100 to 300 mm Hg) in-
creased contractile response of HSV grafts to phenyleph-
rine and depolarization by KCl, pressure distension at 600
mm Hg considerably reduced the responses. This may be
explained partly by the orientation of the smooth muscle
cells within the venous medial layer that allows them to
naturally vary radial dimensions and adjust capacitance at
moderate pressure.
When an excessive amount of force is exerted on the
veins, contractility is abolished, possibly due to physical
disruption of the vessel. In our porcine model, radial dis-
tension did not significantly decrease contractility of the
PSVs. It is possible that PSV was more recalcitrant to the
distension pressure 300 mm Hg in our study. Our data
further suggest that distension or radial stretch injury alone
may not explain the loss of smooth muscle viability in vein
Fig 4. Mechanical stretch injuries reduced contractile re
veins (n 4) harvested using the “no-touch” technique
Segments were suspended in a muscle bath, contracted w
N/m2) At least two segments from each PSV porcine saph
represented averaged stress for each treatment. The errografts. wMost HSVs harvested for CABG at our institutions are
btained by using minimally invasive techniques with en-
oscopy. HSVs obtained from patients undergoing CABG
isplayed inferior contractile responsiveness compared with
hose collected from patients undergoing peripheral vascu-
ar surgery, implicating that technical aspects of endoscopic
arvest of the graft may play a role in vascular smooth
uscle injury. Although histologic examinations have
hown no difference or significant damage to the structural
ntegrity of the tunica intima, media, or adventitia between
ifferent harvesting techniques,24-26 our PSV model dem-
nstrated that longitudinal and angular stretch, both com-
only employed during endovascular harvesting, attenu-
ted the contractility of smooth muscle in the conduit. It is
ossible that stretching of the tissue disrupts the junctional
rganization of the medial layer, causing a breakdown of
ignal and energy transduction in the smooth muscle.27
oldman et al28 demonstrated the mechanical stretch me-
iates degradation of -actin filaments in vascular smooth
uscle. Mechanical stretch also activates the p38 mitogen-
ctivated protein kinase,29-31 nitric oxide,32 and reactive
xygen species pathways,31 causes release of adenosine
riphosphate,33 activates inflammatory pathways,34,35 and
ltimately potentiates apoptosis and proliferation of
mooth muscle cells in the vein grafts. These acute inflam-
atory effects may contribute to thrombosis and early
ostoperative graft failure. Furthermore, stretch-induced
odulation of genes involved in myogenic differentiation
eg, the smooth muscle -actin,36 SM-22,37 and vascular
ndothelial growth factor38) contributes to the vascular
emodeling that underlies pathologic complications, such
s neointima development and atherosclerosis, of the vein
rafts.
IMITATIONS
The present study used deidentified, discarded tis-
ues and was not designed to gather intraoperative data
egarding the procurement technique used. It is also
imited by the lack of information regarding the region,
e in a porcine saphenous vein model. Porcine saphenous
subjected to (A) longitudinal or (B) angular stretching.
Cl, and force was measured and converted to stress (105
s vein were tested for each treatment and averaged. Data
show the standard error of the mean. *P  .05.spons
were
ith K
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Volume 53, Number 2 Hocking et al 459harvested, and long-term follow-up to infer how smooth
muscle viability affects HSV graft patency. Furthermore,
patient demographics are not available and may contrib-
ute to the variability of the response toward injuries
during harvest and explain the susceptibility of injuries in
HSV.
CONCLUSIONS
The principle finding in our study illustrates the adverse
effects of longitudinal and right angle stretch during har-
vest on smoothmuscle function. These injuries are not only
detrimental to the vasomotor function of the vein grafts but
may also be responsible for the responses that initiate the
smooth muscle cells to undergo apoptosis, migrate, and
proliferate, resulting in neointima formation. Taken to-
gether, ameliorating these injuries at the time of harvest
and graft preparation before implantation into the arterial
circulation may limit the activation of the cascade of events
that lead to intimal hyperplasia. Our findings strongly posit
the much-needed development for alternatives to preserve
smooth muscle viability of the vein graft, hence increasing
vein graft patency.
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